The Finances of Egg Donation

Chapter

Abstract

Egg donation has always been a relatively expensive form of assisted reproduction. This is partly due to the obvious fact that in most cases, the donor receives financial compensation for the performance of her service, as well as the extra costs associated with screening the donor prior to her acceptance into the program. However, the discrepancies presently seen in cost between conventional IVF and donor egg IVF were not always so great. For instance, in 1990 patients were typically spending approximately $5,000–7,000 with medications for a cycle of in vitro fertilization, whereas egg donation averaged around $9,000–10,000. In 2012, including the cost of drugs, IVF in most American centers costs around $10,000, whereas a donor egg cycle commonly runs $25,000 or more per attempt.

Egg donation has become increasingly expensive due to several factors related to the egg donor portion of the treatment cycle and not to the process of IVF itself. In addition to normal medical services that must be paid for by the recipients, inflated donor compensation and state and federal regulatory requirements have steadily and substantially increased the cost of doing the business of egg donation over the last 20 years.

Keywords

Insurance Coverage Income Expense Infertility Argentina 

References

  1. 1.
    Glujovsky D, Fiszbajn G, Lipowicz R, Lavolpe M, Sueldo C. Practice of sharing donor oocytes among ­several recipients. Fertil Steril. 2006;86(6):1786–1788.PubMedCrossRefGoogle Scholar
  2. 2.
    Henne MB, Bundorf MK. Insurance mandates and trends in infertility treatments. Fertil Steril. 2008;89(1):66–73.PubMedCrossRefGoogle Scholar
  3. 3.
    Levens ED, Levy MJ. Ethical application of shared risk programs in assisted reproductive technology. Fertil Steril. 2011;95(7):2198–9.PubMedCrossRefGoogle Scholar
  4. 4.
    Ethics Committee of the American Society for Reproductive Medicine. Shared-risk or refund programs in assisted reproduction. Fertil Steril. 2004;82 Suppl 1:S249–50.Google Scholar
  5. 5.
    Heng BC. Egg sharing in return for subsidized fertility treatment–ethical challenges and pitfalls. J Assist Reprod Genet. 2008;25(4):159–61.PubMedCrossRefGoogle Scholar
  6. 6.
    Gorrill MJ, et al. Oocyte donor screening: the selection process and cost analysis. Fertil Steril. 2001;75(2):400–4.PubMedCrossRefGoogle Scholar
  7. 7.
    Baker VL, et al. Economic cost for implementation of the U.S. Food and Drug Administration’s Code of Federal Regulations Title 21, Part 1271 in an egg donor program. Fertil Steril. 2008;90(3):537–45.PubMedCrossRefGoogle Scholar
  8. 8.
    Covington SN, Gibbons WE. Society for assisted reproductive, what is happening to the price of eggs? Fertil Steril. 2007;87(5):1001–4.PubMedCrossRefGoogle Scholar
  9. 9.
    Ethics Committee Of The American Society For Reproductive Medicine. Financial compensation of oocyte donors. Fertil Steril. 2007;88(2):305–9.CrossRefGoogle Scholar

Copyright information

© Springer-Verlag London 2013

Authors and Affiliations

  1. 1.Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, College of Physicians and SurgeonsColumbia University, New York Presbyterian Hospital-Columbia University Medical CenterNew YorkUSA
  2. 2.Department of Obstetrics and Gynecology, College of Physicians and SurgeonsColumbia University, New York Presbyterian Hospital-Columbia University Medical CenterNew YorkUSA

Personalised recommendations